What is the ticker symbol for Cartesian Therapeutics?

Cartesian Therapeutics trades under the ticker RNAC on NASDAQ.

What sector does Cartesian Therapeutics operate in?

Cartesian Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze RNAC in a portfolio?

PortView shows RNAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cartesian Therapeutics (RNAC) Stock Analysis

NASDAQHealthcareBiotechnology

$8.95-3.81%

1-year price historyRange $5.84 – $10.64

52-week range$8.95

$5.60$11.00

What Cartesian Therapeutics does

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.

Key metrics

Market cap

$262.84M

P/E (TTM)

-2.38

EPS (TTM)

$-3.76

Beta

0.56

Dividend yield

0.00%

Revenue / share

$0.05

50-day avg

$9.07

200-day avg

$7.65

52-week high

$11.00

52-week low

$5.60

CEO

Carsten Brunn

ETFs linked to RNAC

Broad-market and Healthcare sector ETFs an investor holding Cartesian Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how RNAC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RNAC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cartesian Therapeutics?: Cartesian Therapeutics trades under the ticker RNAC on NASDAQ.
Which exchange is RNAC listed on?: RNAC is listed on NASDAQ.
What sector does Cartesian Therapeutics operate in?: Cartesian Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze RNAC in a portfolio?: PortView shows RNAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.